中国经济时报记者 段树军“AI及生成式AI的快速演进让我们非常深刻地认同,在生物医药这样高技术投入、高不确定性的行业,人工智能这个新生产力是我们必须要去拥抱的。”6月19日,在上海举行的2025亚马逊云科技中国峰会上,复星医药总裁助理兼首席数智官林锦斌分享了复星医药智能化战略的思考。2024年,复星医药凭借其在数字化领域持续深耕,入选长三角地区民营企业发展新质生产力数字化转型典型样本。迎接智能化...
Source Link中国经济时报记者 段树军“AI及生成式AI的快速演进让我们非常深刻地认同,在生物医药这样高技术投入、高不确定性的行业,人工智能这个新生产力是我们必须要去拥抱的。”6月19日,在上海举行的2025亚马逊云科技中国峰会上,复星医药总裁助理兼首席数智官林锦斌分享了复星医药智能化战略的思考。2024年,复星医药凭借其在数字化领域持续深耕,入选长三角地区民营企业发展新质生产力数字化转型典型样本。迎接智能化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.